Non-familial Alzheimer's disease is mainly due to genetic factors

被引:109
作者
Ashford, J. Wesson [1 ,2 ]
Mortimer, James A. [3 ]
机构
[1] Univ Kentucky, Vet Affairs Med Ctr, Sanders Brown Ctr Aging, Dept Psychiat, Lexington, KY 40536 USA
[2] Univ Kentucky, Vet Affairs Med Ctr, Sanders Brown Ctr Aging, Dept Neurol, Lexington, KY 40536 USA
[3] Univ S Florida, Inst Aging, Tampa, FL USA
关键词
D O I
10.3233/JAD-2002-4307
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This team takes the position that what is commonly referred to as non-familial Alzheimer's disease (AD) is predominantly due to genetic factors. Population-based studies suggest that genetic factors cause the majority of cases that begin after age 60. There are several lines of evidence supporting this position: - Data from the Nun Study suggest that the risk for AD is largely established by early adulthood, implying that later adult exposures likely play only a small role in causation. - Family studies show that first-degree blood relatives of persons with non-familial AD have a substantially increased risk of AD relative to controls. - Twin studies suggest that the heritability of AD exceeds 60%. - Environmental factors, such as socioeconomic status, education, and head injury, are strong risk factors for AD only in individuals with a genetic predisposition. - The APOE genotype is a powerful risk factor for AD and accounts for as much as 50% of AD in many populations. - There are numerous other candidate genes with strong associations with AD that presumably explain the remaining population risk. This paper further reviews the mechanisms associated with AD causation for APOE and other candidate genes and implications for the development of prevention strategies.
引用
收藏
页码:169 / 177
页数:9
相关论文
共 66 条
  • [1] Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease
    Arendt, T
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2001, 19 (03) : 231 - 245
  • [2] Ashford J.W., 1998, ADV DIAGNOSIS TREATM, P53
  • [3] Ashford J.W., 2001, EXPERT REV NEUROTHER, V1, P89
  • [4] ASHFORD JW, 1985, NEW ENGL J MED, V313, P388
  • [5] Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264
  • [6] ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
    Blacker, D
    Haines, JL
    Rodes, L
    Terwedow, H
    Go, RCP
    Harrell, LE
    Perry, RT
    Bassett, SS
    Chase, G
    Meyers, D
    Albert, MS
    Tanzi, R
    [J]. NEUROLOGY, 1997, 48 (01) : 139 - 147
  • [7] Alpha-2 macroglobulin is genetically associated with Alzheimer disease
    Blacker, D
    Wilcox, MA
    Laird, NM
    Rodes, L
    Horvath, SM
    Go, RCP
    Perry, R
    Watson, B
    Bassett, SS
    McInnis, MG
    Albert, MS
    Hyman, BT
    Tanzi, RE
    [J]. NATURE GENETICS, 1998, 19 (04) : 357 - 360
  • [8] APOE-ε4 count predicts age when prevalence of AD increases, then declines -: The Cache County Study
    Breitner, JCS
    Wyse, BW
    Anthony, JC
    Welsh-Bohmer, KA
    Steffens, DC
    Norton, MC
    Tschanz, JT
    Plassman, BL
    Meyer, MR
    Skoog, I
    Khachaturian, A
    [J]. NEUROLOGY, 1999, 53 (02) : 321 - 331
  • [9] CLINICAL GENETICS AND GENETIC-COUNSELING IN ALZHEIMER-DISEASE
    BREITNER, JCS
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 601 - 606
  • [10] Codemo A., 2000, NEUROBIOL AGING, V21, pS246